Clinical Trial Update: Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update for a phase 1/2 study evaluating EGFRBi armed fresh PBMC in patients with metastatic or unresectable pancreatic cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• EGFRBi armed fresh PBMC

Snippet

Sponsor: University of Virginia | Conditions: Pancreas Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING